Advances in the discovery of novel agents for the treatment of glaucoma
Author:
Affiliation:
1. U.O. Oculistica Az. USL 3, Val Di Nievole, Ospedale Di Pescia, Pescia, Italy
2. Università Degli Studi Di Firenze, NEUROFARBA Department, Sezione Di Scienze Farmaceutiche E Nutraceutiche, Sesto Fiorentino (Firenze), Italy
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2021.1922384
Reference125 articles.
1. Current management of glaucoma
2. Novel therapies for glaucoma: a patent review (2013-2019)
3. Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics
4. Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
5. Causative glaucoma treatment: promising targets and delivery systems
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring Natural Product Derivatives having Carbonic Anhydrase Inhibitory Activity;Journal of Natural Remedies;2024-05-28
2. Lupane acetates in small molecule drug hybrids: Probing their inhibitory activity for carbonic anhydrase II;European Journal of Medicinal Chemistry Reports;2024-04
3. Drug interactions of carbonic anhydrase inhibitors and activators;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03
4. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma;Journal of Medicinal Chemistry;2024-01-11
5. Synthesis of new class of non-sulfonamide bis-benzimidazoles as antitumor agents by inhibiting carbonic anhydrase-IX enzyme;International Journal of Biological Macromolecules;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3